Financials
- Market Capitalization 434.3 M
- Employee 231
- Founded 2005
- CEO Linda Marban
- Website www.capricor.com
- Headquarter Delaware, United States
- FIGI BBG000DZMK99
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.77
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2939 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 8.20 USD | -1.56% | -3.53% | +26.35% | +16.48% | 442.19 M USD | ||
| 2947 | TECX Tectonic Therapeutic, Inc. - Common Stock | 22.35 USD | -4.20% | -3.46% | -23.95% | +30.32% | 436.93 M USD | ||
| 2955 | PRTA Prothena Corporation plc - Ordinary Shares | 8.43 USD | -4.64% | +1.81% | -5.81% | -18.31% | 432.77 M USD | ||
| 2977 | EDIT Editas Medicine, Inc. - Common Stock | 2.75 USD | -5.17% | -3.51% | +2.23% | -20.06% | 422.35 M USD |